



Tesamorelin is a synthetic analogue of Growth Hormone Releasing Hormone designed to stimulate the release of endogenous growth hormone from the pituitary gland. It is structurally modified to improve stability and biological activity compared to naturally occurring GHRH.
Tesamorelin has been widely studied in metabolic and endocrine research due to its influence on growth hormone and Insulin-like Growth Factor 1 signalling pathways.
R400,00 – R1 400,00Price range: R400,00 through R1 400,00
Key Research Areas & Observed Effects
In clinical and laboratory research, Tesamorelin has been associated with:
Stimulation of endogenous growth hormone release
Increased IGF-1 signalling in experimental models
Investigation into fat metabolism and body composition
Influence on metabolic and endocrine pathways
Support for studies involving visceral adipose tissue regulation
Research into growth hormone-related signalling and recovery pathways
Unlike many research peptides, Tesamorelin has undergone more extensive clinical evaluation in specific medical contexts.
Mechanism of Action (Research Insights)
Tesamorelin works primarily through activation of the body’s natural growth hormone system:
GHRH Receptor Activation:
It binds to receptors in the pituitary gland, stimulating the release of endogenous growth hormone.
Growth Hormone & IGF-1 Signalling:
Increased growth hormone release can influence IGF-1 production and related metabolic pathways.
Metabolic Regulation:
Research has explored its effects on fat metabolism, particularly in relation to visceral adipose tissue.
Endocrine System Interaction:
Tesamorelin is studied for its role in regulating hormonal signalling without directly supplying exogenous growth hormone.
Scientific Applications
Tesamorelin is commonly studied in research involving:
Growth hormone regulation
Metabolic and body composition studies
Endocrine signalling pathways
Fat metabolism and visceral adipose tissue research
Recovery and regenerative investigations
Its extended clinical research background distinguishes it from many other peptides in this category
Summary
Tesamorelin is a synthetic GHRH analogue widely studied for its effects on growth hormone signalling, metabolism, and endocrine regulation. Ongoing research continues to explore its broader applications and long-term effects across metabolic and recovery-related fields.
Important Disclaimer
Tesamorelin may be regulated differently depending on jurisdiction and intended use. Any products supplied in research format are intended strictly for scientific, laboratory, and educational purposes only.
This information should not be interpreted as medical advice or guidance for personal use.
Reconstitution Guide:
Add bacteriostatic or sterile water carefully to achieve the desired concentration. Allow the solution to dissolve gently—avoid vigorous shaking.
Storage Guidelines:
Unreconstituted: Store refrigerated or frozen according to laboratory protocol
Reconstituted: Refrigerate (2–8 °C) and use within recommended timeframes
Protect from light and avoid repeated freeze-thaw cycles